The FOCIS 2026 Annual Meeting is the premier conference dedicated to translational immunology, designed to provide professionals with a competitive edge in their careers. The event brings together leading clinicians and researchers to deliver the latest breakthroughs across a wide range of immune-mediated diseases. The core focus is on exploring molecular pathways and their implications in human disease, which creates a unique environment for innovative thinking. Attendees can apply ideas and solutions from the pathology of one disease to uncover novel therapeutic strategies for others they are currently studying.

Through this annual meeting, researchers and clinicians collaboratively share knowledge that transcends traditional disease boundaries. The goal is to identify commonalities in treatments and therapies that have the potential to be life-changing for patients. The past two decades have been transformational for those living with immune-mediated conditions, from the introduction of monoclonal antibodies to recent advancements in cancer immunotherapy, and the FOCIS meeting serves to continue driving this progress forward.